Skip to content

Serratus and Parasternal Infrapectoral Block for Breast Surgery.

Post-Op Complication | Breast Pain

Effective pain control is important following breast surgery as it improves quality of recovery, decreases the risk of chronic pain development and reduction of overall health care cost. Current strategies of pain management for breast surgery include use of opioid medication or addition of regional anesthesia along with general anesthesia. Serratus block and parasternal infrapectoral blocks are newly developed fascial plane blocks that are technically easy to perform, effective and safe based on our daily clinical practice and published evidence. We are comparing the addition of serratus and parasternal infrapectoral nerve block with general anesthesia to a combination of placebo and general anesthesia for breast reduction surgery. We propose that this would result in an improved efficiency resulting in early hospital discharge and improve quality of patient care, following breast reduction surgery.

null

Participation Requirements

  • Sex:

    FEMALE

  • Eligible Ages:

    18 to 80

Participation Criteria

Inclusion Criteria:

* women aged 18-80 years
* ASA I to III (American Society of Anesthesiologists Physical Status Classification System)
* Undergoing unilateral oncoplastic breast reduction mammoplasty, simple mastectomy surgery, or lumpectomy at St. Joseph's Hospital.
* Day surgery procedures

Exclusion Criteria:

* Inability to understand or to provide consent
* Inability or unwillingness to comply with required follow-up assessments
* Psychiatric disorder affecting patient assessment
* Contraindication to regional anesthesia, e.g. coagulopathy
* Allergy to local anesthetic
* Chronic pain and/or chronic use of opioids with a daily use of over 30 mg oxycodone or equivalent per day
* Contraindication to a component of multimodal analgesia
* Preexisting neuropathy with motor or sensory deficits in the area of the anterolateral chest wall
* Infection near injection site
* Pregnancy
* BMI\>40
* Complication or adverse events unrelated to the study intervention that precludes evaluation of the primary and secondary outcomes.

Study Location

St. Joseph's Hospital
St. Joseph's Hospital
London, Ontario
Canada

Contact Study Team

Primary Contact

Abhijit Biswas, MD

[email protected]
(416) 830-1696
Study Sponsored By
Western University, Canada
Participants Required
More Information
Study ID: NCT03708302